| Ontario Health - Cancer Care Ontario's Data Book - 2022-2023 |
|
Updated October 2022
Monthly updates (in-year) will be posted in this section on an ongoing basis.
Data book Release Notes
|
Item |
Update |
| December 2021 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.14 - NHPIP Code List | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| January 2022 | |
| I - Activity Level Reporting (ALR) - Radiation Planning / Treatment Activity - Course of Radiation Treatment - Format and Valid Values | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.36 - ICDO3 Morphology Codes | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.39 - Clinical Practice Group Mapping | Updated |
| I - Activity Level Reporting (ALR) - Specifications - QA Specifications - Master List of QA Checks | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| February 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.14 - NHPIP Code List | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1-1 - OHRS - MIS Functional Centres | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1-1-2 - National Standard - MIS Functional Centres | Updated |
| March 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| April 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix A - MOHLTC Master Numbering System | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.13 - Responsibility for Payment Codes | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.24 - Diagnosis / Gender Incompatibilities Validation tables | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.18 - ICD10CA Master Code/Description list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.36 - ICDO3 Morphology Codes | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| May 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| IIC - Wait Time Information System (WTIS) - Introduction | Updated |
| June 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.39 - Clinical Practice Group Mapping | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.34 - Reporting Facilities | Updated |
| 01 Introduction - Frequently Asked Questions (FAQ) about DataBook - FAQ # 30 | Updated |
| I - Activity Level Reporting (ALR) - Specifications - ALR - Submission Schedule FY 2022/2023 | Updated |
| August 2022 | |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.14 - NHPIP Code List | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol | Updated |
| I - Activity Level Reporting (ALR) - Appendix - Appendix 1.36 - ICDO3 Morphology Codes | Updated |
|
September 2022 |
|
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list |
Updated |
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.14 - NHPIP Code List |
Updated |
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol |
Updated |
|
I - Activity Level Reporting (ALR) - Patient - Patient Gender - Valid Values |
Updated |
|
I - Introduction - Frequently Asked Questions (FAQ) about Data Book - #6 |
Updated |
|
October 2022 |
|
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 - STFM Drug Classification - Antineoplastic and Supportive Drug list |
Updated |
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.14 - NHPIP Code List |
Updated |
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol |
Updated |
|
I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen |
Updated |
|
I - Activity Level Reporting (ALR) - Specifications - QA Specifications - Master List of QA Checks |
Updated |